332 related articles for article (PubMed ID: 22093405)
1. [Carbohydrate antigen 125 serial measurements after an admission for acute heart failure and risk of early readmission].
Miñana Escrivá G; Núñez J; Sanchis J; Bodi V; Núñez E; Chorro FJ; Llàcer A
Med Clin (Barc); 2012 Nov; 139(11):479-86. PubMed ID: 22093405
[TBL] [Abstract][Full Text] [Related]
2. Antigen carbohydrate 125 and brain natriuretic peptide serial measurements for risk stratification following an episode of acute heart failure.
Núñez J; Núñez E; Sanchis J; Bodí V; Fonarow GC; Miñana G; Palau P; Bertomeu-González V; Carratalá A; Mainar L; Chorro FJ; Llàcer A
Int J Cardiol; 2012 Aug; 159(1):21-8. PubMed ID: 21367474
[TBL] [Abstract][Full Text] [Related]
3. Antigen carbohydrate 125 and creatinine on admission for prediction of renal function response following loop diuretic administration in acute heart failure.
Núñez J; Llàcer P; Núñez E; Ventura S; Bonanad C; Bodí V; Miñana G; Santas E; Mascarell B; Fonarow GC; Chorro FJ; Sanchis J
Int J Cardiol; 2014 Jul; 174(3):516-23. PubMed ID: 24801083
[TBL] [Abstract][Full Text] [Related]
4. Carbohydrate Antigen-125-Guided Therapy in Acute Heart Failure: CHANCE-HF: A Randomized Study.
Núñez J; Llàcer P; Bertomeu-González V; Bosch MJ; Merlos P; García-Blas S; Montagud V; Bodí V; Bertomeu-Martínez V; Pedrosa V; Mendizábal A; Cordero A; Gallego J; Palau P; Miñana G; Santas E; Morell S; Llàcer A; Chorro FJ; Sanchis J; Fácila L;
JACC Heart Fail; 2016 Nov; 4(11):833-843. PubMed ID: 27522630
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of carbohydrate antigen 125 combined with N-terminal pro B-type natriuretic peptide in patients with acute heart failure.
Chen X; Wu M; Xu K; Huang M; Zhuo X
Acta Cardiol; 2021 Feb; 76(1):87-92. PubMed ID: 32519930
[TBL] [Abstract][Full Text] [Related]
6. Long-term serial kinetics of N-terminal pro B-type natriuretic peptide and carbohydrate antigen 125 for mortality risk prediction following acute heart failure.
Núñez J; Núñez E; Bayés-Genís A; Fonarow GC; Miñana G; Bodí V; Pascual-Figal D; Santas E; Garcia-Blas S; Chorro FJ; Rizopoulos D; Sanchis J
Eur Heart J Acute Cardiovasc Care; 2017 Dec; 6(8):685-696. PubMed ID: 27199489
[TBL] [Abstract][Full Text] [Related]
7. Clinical utility of antigen carbohydrate 125 for planning the optimal length of stay in acute heart failure.
Lorenzo M; Palau P; Llàcer P; Domínguez E; Ventura B; Núñez G; Miñana G; Solsona J; Santas E; De La Espriella R; Bodí V; Núñez E; Sanchis J; Bayés-Genís A; Núñez J
Eur J Intern Med; 2021 Oct; 92():94-99. PubMed ID: 34130879
[TBL] [Abstract][Full Text] [Related]
8. Differential mortality association of loop diuretic dosage according to blood urea nitrogen and carbohydrate antigen 125 following a hospitalization for acute heart failure.
Núñez J; Núñez E; Miñana G; Bodí V; Fonarow GC; Bertomeu-González V; Palau P; Merlos P; Ventura S; Chorro FJ; Llàcer P; Sanchis J
Eur J Heart Fail; 2012 Sep; 14(9):974-84. PubMed ID: 22700856
[TBL] [Abstract][Full Text] [Related]
9. Risk stratification with the use of serial N-terminal pro-B-type natriuretic peptide measurements during admission and early after discharge in heart failure patients: post hoc analysis of the PRIMA study.
Eurlings LW; Sanders-van Wijk S; van Kraaij DJ; van Kimmenade R; Meeder JG; Kamp O; van Dieijen-Visser MP; Tijssen JG; Brunner-La Rocca HP; Pinto YM
J Card Fail; 2014 Dec; 20(12):881-90. PubMed ID: 25175696
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of Osteoprotegerin in Acute Heart Failure.
Friões F; Laszczynska O; Almeida PB; Silva N; Guimarães JT; Omland T; Azevedo A; Bettencourt P
Can J Cardiol; 2015 Oct; 31(10):1266-71. PubMed ID: 26143141
[TBL] [Abstract][Full Text] [Related]
11. Carbohydrate antigen 125: an emerging prognostic risk factor in acute heart failure?
Núñez J; Núñez E; Consuegra L; Sanchis J; Bodí V; Martínez-Brotons A; Bertomeu-González V; Robles R; Bosch MJ; Fácila L; Darmofal H; Llàcer A
Heart; 2007 Jun; 93(6):716-21. PubMed ID: 17164487
[TBL] [Abstract][Full Text] [Related]
12. Tumor marker carbohydrate antigen 125 predicts adverse outcome after transcatheter aortic valve implantation.
Husser O; Núñez J; Núñez E; Holzamer A; Camboni D; Luchner A; Sanchis J; Bodi V; Riegger GA; Schmid C; Hilker M; Hengstenberg C
JACC Cardiovasc Interv; 2013 May; 6(5):487-96. PubMed ID: 23702013
[TBL] [Abstract][Full Text] [Related]
13. Optimal carbohydrate antigen 125 cutpoint for identifying low-risk patients after admission for acute heart failure.
Núñez J; Bayés-Genís A; Revuelta-López E; Miñana G; Santas E; Ter Maaten JM; de la Espriella R; Carratalá A; Lorenzo M; Palau P; Llàcer P; Valle A; Bodi V; Núñez E; Lupón J; Lang C; Ng LL; Metra M; Sanchis J; Voors AA
Rev Esp Cardiol (Engl Ed); 2022 Apr; 75(4):316-324. PubMed ID: 33745912
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of the interaction between galectin-3 and antigen carbohydrate 125 in acute heart failure.
Núñez J; Rabinovich GA; Sandino J; Mainar L; Palau P; Santas E; Villanueva MP; Núñez E; Bodí V; Chorro FJ; Miñana G; Sanchis J
PLoS One; 2015; 10(4):e0122360. PubMed ID: 25875367
[TBL] [Abstract][Full Text] [Related]
15. Procalcitonin and long-term prognosis after an admission for acute heart failure.
Villanueva MP; Mollar A; Palau P; Carratalá A; Núñez E; Santas E; Bodí V; Chorro FJ; Miñana G; Blasco ML; Sanchis J; Núñez J
Eur J Intern Med; 2015 Jan; 26(1):42-8. PubMed ID: 25592074
[TBL] [Abstract][Full Text] [Related]
16. [Benefits of statin therapy based on plasma carbohydrate antigen 125 values following an admission for acute heart failure].
Núñez J; Sanchis J; Núñez E; Fonarow GC; Bodí V; Bertomeu-González V; Miñana G; Palau P; Fácila L; Chorro FJ; Bertomeu-Martínez V; Llàcer A
Rev Esp Cardiol; 2011 Dec; 64(12):1100-8. PubMed ID: 21958731
[TBL] [Abstract][Full Text] [Related]
17. Serum aldosterone is associated with mortality and re-hospitalization in patients with reduced ejection fraction hospitalized for acute heart failure: analysis from the EVEREST trial.
Girerd N; Pang PS; Swedberg K; Fought A; Kwasny MJ; Subacius H; Konstam MA; Maggioni A; Gheorghiade M; Zannad F;
Eur J Heart Fail; 2013 Nov; 15(11):1228-35. PubMed ID: 23787720
[TBL] [Abstract][Full Text] [Related]
18. Clinical Role of CA125 in Worsening Heart Failure: A BIOSTAT-CHF Study Subanalysis.
Núñez J; Bayés-Genís A; Revuelta-López E; Ter Maaten JM; Miñana G; Barallat J; Cserkóová A; Bodi V; Fernández-Cisnal A; Núñez E; Sanchis J; Lang C; Ng LL; Metra M; Voors AA
JACC Heart Fail; 2020 May; 8(5):386-397. PubMed ID: 32171764
[TBL] [Abstract][Full Text] [Related]
19. Carbohydrate antigen 125 and risk of heart failure readmissions in patients with heart failure and preserved ejection fraction.
Miñana G; de la Espriella R; Palau P; Llácer P; Núñez E; Santas E; Valero E; Lorenzo M; Núñez G; Bodí V; Heredia R; Sanchis J; Bayés-Genís A; Chorro FJ; Núñez J
Sci Rep; 2022 Jan; 12(1):1344. PubMed ID: 35079082
[TBL] [Abstract][Full Text] [Related]
20. Bioelectrical impedance vector analysis and clinical outcomes in patients with acute heart failure.
Núñez J; Mascarell B; Stubbe H; Ventura S; Bonanad C; Bodí V; Núñez E; Miñana G; Fácila L; Bayés-Genis A; Chorro FJ; Sanchis J
J Cardiovasc Med (Hagerstown); 2016 Apr; 17(4):283-90. PubMed ID: 25333379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
